318 related articles for article (PubMed ID: 24820353)
1. Cell therapy to remove excess copper in Wilson's disease.
Gupta S
Ann N Y Acad Sci; 2014 May; 1315(1):70-80. PubMed ID: 24820353
[TBL] [Abstract][Full Text] [Related]
2. In
Sharma Y; Liu J; Kristian KE; Follenzi A; Gupta S
Gene Expr; 2018 Dec; 19(1):15-24. PubMed ID: 30029699
[TBL] [Abstract][Full Text] [Related]
3. Structural and metabolic changes in Atp7b-/- mouse liver and potential for new interventions in Wilson's disease.
Huster D
Ann N Y Acad Sci; 2014 May; 1315():37-44. PubMed ID: 24697742
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte transplantation in the Long Evans Cinnamon rat model of Wilson's disease.
Park SM; Vo K; Lallier M; Cloutier AS; Brochu P; Alvarez F; Martin SR
Cell Transplant; 2006; 15(1):13-22. PubMed ID: 16700326
[TBL] [Abstract][Full Text] [Related]
5. Rescue of ATP7B function in hepatocyte-like cells from Wilson's disease induced pluripotent stem cells using gene therapy or the chaperone drug curcumin.
Zhang S; Chen S; Li W; Guo X; Zhao P; Xu J; Chen Y; Pan Q; Liu X; Zychlinski D; Lu H; Tortorella MD; Schambach A; Wang Y; Pei D; Esteban MA
Hum Mol Genet; 2011 Aug; 20(16):3176-87. PubMed ID: 21593220
[TBL] [Abstract][Full Text] [Related]
6. Activation of HIF-1 signaling ameliorates liver steatosis in zebrafish atp7b deficiency (Wilson's disease) models.
Mi X; Li Z; Yan J; Li Y; Zheng J; Zhuang Z; Yang W; Gong L; Shi J
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165842. PubMed ID: 32446740
[TBL] [Abstract][Full Text] [Related]
7. Laser ablation inductively coupled plasma mass spectrometry imaging of metals in experimental and clinical Wilson's disease.
Boaru SG; Merle U; Uerlings R; Zimmermann A; Flechtenmacher C; Willheim C; Eder E; Ferenci P; Stremmel W; Weiskirchen R
J Cell Mol Med; 2015 Apr; 19(4):806-14. PubMed ID: 25704483
[TBL] [Abstract][Full Text] [Related]
8. Correction of liver disease following transplantation of normal rat hepatocytes into Long-Evans Cinnamon rats modeling Wilson's disease.
Irani AN; Malhi H; Slehria S; Gorla GR; Volenberg I; Schilsky ML; Gupta S
Mol Ther; 2001 Mar; 3(3):302-9. PubMed ID: 11273771
[TBL] [Abstract][Full Text] [Related]
9. Demonstrating Potential of Cell Therapy for Wilson's Disease with the Long-Evans Cinnamon Rat Model.
Jaber FL; Sharma Y; Gupta S
Methods Mol Biol; 2017; 1506():161-178. PubMed ID: 27830552
[TBL] [Abstract][Full Text] [Related]
10. Intracellular distribution of the Wilson's disease gene product (ATPase7B) after in vitro and in vivo exogenous expression in hepatocytes from the LEC rat, an animal model of Wilson's disease.
Nagano K; Nakamura K; Urakami KI; Umeyama K; Uchiyama H; Koiwai K; Hattori S; Yamamoto T; Matsuda I; Endo F
Hepatology; 1998 Mar; 27(3):799-807. PubMed ID: 9500710
[TBL] [Abstract][Full Text] [Related]
11. Fragmentation of mitochondrial cardiolipin by copper ions in the Atp7b-/- mouse model of Wilson's disease.
Yurkova IL; Arnhold J; Fitzl G; Huster D
Chem Phys Lipids; 2011 Jul; 164(5):393-400. PubMed ID: 21645498
[TBL] [Abstract][Full Text] [Related]
12. ATP7B (WND) protein.
Terada K; Schilsky ML; Miura N; Sugiyama T
Int J Biochem Cell Biol; 1998 Oct; 30(10):1063-7. PubMed ID: 9785470
[TBL] [Abstract][Full Text] [Related]
13. Early gestational gene transfer with targeted ATP7B expression in the liver improves phenotype in a murine model of Wilson's disease.
Roybal JL; Endo M; Radu A; Gray L; Todorow CA; Zoltick PW; Lutsenko S; Flake AW
Gene Ther; 2012 Nov; 19(11):1085-94. PubMed ID: 22158007
[TBL] [Abstract][Full Text] [Related]
14. Defective cellular localization of mutant ATP7B in Wilson's disease patients and hepatoma cell lines.
Huster D; Hoppert M; Lutsenko S; Zinke J; Lehmann C; Mössner J; Berr F; Caca K
Gastroenterology; 2003 Feb; 124(2):335-45. PubMed ID: 12557139
[TBL] [Abstract][Full Text] [Related]
15. Atp7b-/- mice as a model for studies of Wilson's disease.
Lutsenko S
Biochem Soc Trans; 2008 Dec; 36(Pt 6):1233-8. PubMed ID: 19021531
[TBL] [Abstract][Full Text] [Related]
16. Localization of the Wilson's disease protein in human liver.
Schaefer M; Roelofsen H; Wolters H; Hofmann WJ; Müller M; Kuipers F; Stremmel W; Vonk RJ
Gastroenterology; 1999 Dec; 117(6):1380-5. PubMed ID: 10579979
[TBL] [Abstract][Full Text] [Related]
17. Liver cell transplantation leads to repopulation and functional correction in a mouse model of Wilson's disease.
Allen KJ; Cheah DM; Wright PF; Gazeas S; Pettigrew-Buck NE; Deal YH; Mercer JF; Williamson R
J Gastroenterol Hepatol; 2004 Nov; 19(11):1283-90. PubMed ID: 15482536
[TBL] [Abstract][Full Text] [Related]
18. Long-term metabolic correction of Wilson's disease in a murine model by gene therapy.
Murillo O; Luqui DM; Gazquez C; Martinez-Espartosa D; Navarro-Blasco I; Monreal JI; Guembe L; Moreno-Cermeño A; Corrales FJ; Prieto J; Hernandez-Alcoceba R; Gonzalez-Aseguinolaza G
J Hepatol; 2016 Feb; 64(2):419-426. PubMed ID: 26409215
[TBL] [Abstract][Full Text] [Related]
19. Urinary copper elevation in a mouse model of Wilson's disease is a regulated process to specifically decrease the hepatic copper load.
Gray LW; Peng F; Molloy SA; Pendyala VS; Muchenditsi A; Muzik O; Lee J; Kaplan JH; Lutsenko S
PLoS One; 2012; 7(6):e38327. PubMed ID: 22802922
[TBL] [Abstract][Full Text] [Related]
20. Modifying factors and phenotypic diversity in Wilson's disease.
Lutsenko S
Ann N Y Acad Sci; 2014 May; 1315():56-63. PubMed ID: 24702697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]